A diffuse acoustic confocal imager device for use with a data analyzer for providing a three dimensional and state information on an object based on an at least one phase image, the device comprising a coherent acoustic source for producing an acoustic confocal beam ranging from about 0.5 megahertz to about 100 megahertz, an acoustic coherent beam focuser for focusing the acoustic coherent beam to a virtual source, an acoustic detector for detecting an at least one diffusely scattered beam from the virtual source and a vector network analyzer, which is for measuring a phase of the acoustic confocal beam and a phase of the at least one diffusely scattered beam to provide the at least one phase image, the vector network analyzer in electronic communication with each of the coherent acoustic source and the acoustic detector. A method of detecting and treating diseases such as prostate cancer and ovarian cancer is also provided.

A method for HIFU treatment of localized prostate cancer in a patient includes identifying the cancer locations in a patient's prostate; visually segmenting the patient's prostate into areas for analysis and treatment, where the section including the area of most aggressive cancer is determined to be the primary area. The primary area is subjected to a first full HIFU treatment for a period intended to ablate the cancerous tumor. HIFU treatment is then stopped on the primary area and the primary area is allowed to rest while simultaneously subjecting the next contiguous area of the patient's prostate to a first HIFU treatment to ablate any additional areas of suspected cancer in the next contiguous area. HIFU treatment is then stopped in the contiguous area. The primary area is then subjected to a second full HIFU treatment for a period sufficient to ensure the complete ablation of the cancerous tumor. The method further includes repeating alternating full HIFU treatment processes on subsequent contiguous areas of the patient's prostate to ensure the complete ablation of any cancerous tumors in the patient's prostate. The entire process is completed under one treatment of anesthesia.

An ultrasonic treatment head includes a head body and a cartridge. The head body includes: a body housing for supporting and protecting internal components and providing an interface for a user; a first actuator generating reciprocation on a first axis; a second actuator generating reciprocation on a second axis, and a stage pivoted about a fixed axis by the first actuator and the second actuator. The cartridge includes: a cartridge housing for keeping a transducer and liquid therein; a flat window disposed on the cartridge housing to transmit ultrasonic waves to a treatment area; a body coupler for coupling to the head body; an ultrasonic transducer generating ultrasonic waves in response to an operation signal input through the body coupler; and a fitting assembly moving the ultrasonic transducer on the flat window for in-plane scanning by a pivot motion, which is transmitted through the body coupler, of the stage.

Antimicrobial films for generating singlet oxygen and their use is described. The antimicrobial films are generally thin films having two surfaces or faces. The first surface of the film is adhesive. Various adhesives, including, electrostatic charges, are possible. The second surface faces in a direction opposite from the first surface. The second surface of the film emits singlet oxygen when activated by light or ultrasound. Various photosensitizers can be incorporated onto the second surface of the films for generating the singlet oxygen. The singlet oxygen and other radical species generated from the antimicrobial films diffuses out from and in proximity to the films to form a layer or cloud of singlet oxygen at a concentration sufficient to inactivate microbial particles, e.g., viruses and other pathogens, that come within the singlet oxygen layer to provide a protective zone against microbial particles.

The present disclosure relates to a chlorin derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, an anti-tumor composition including the chlorin derivative or the pharmaceutically acceptable salt thereof, use of the chlorin derivative or the pharmaceutically acceptable salt thereof in the treatment of a tumor, and a combination of the chlorin derivative or the pharmaceutically acceptable salt thereof and an ultrasound medical system. The chlorin derivative or the pharmaceutically acceptable salt thereof has a structure represented by formula (I), and the ultrasonic medical system comprises a transducer ultrasonic bed and a contact agent. The chlorin derivative of the present disclosure can be used in photodynamic therapy and sonodynamic therapy, thereby effectively inhibiting and treating cancer.

Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.

A system to generate and sense electrical energy to and from tissue within a mammalian body. The system includes a flexible shaft and an electrical generator disposed on or embedded within the flexible shaft. Radially displaceable arcuate arm members forming electrodes are displaceable responsive to actuation of the electrical generator.

Methods and systems of evaluating cardiac pacing in candidate patients for cardiac resynchronization therapy and cardiac resynchronization therapy patients are disclosed. The methods and systems disclosed allow treatments to be personalized to patients by measuring the extent of tissue capture from cardiac pacing under various therapy parameter conditions. Systems and methods of optimizing right ventricle only cardiac pacing are also disclosed.

The invention discloses a method and a device to treat vessels. In particular, the invention is directed at a method to occlude varicose veins while avoiding the formation of bubble clouds in the tissue surrounding the vessel and/or their interaction with the ultrasound beam. The invention is further directed at a device adapted to perform the method.

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.